PRPO - Precipio Inc

PRPO - Precipio Inc

https://www.precipiodx.com

Momentum: Bearish

Recent News

Powered by Alpha Vantage

Precipio Terminates Its ATM - Precipio ( NASDAQ:PRPO )

Benzinga • 1 week, 6 days ago • score: 0.19

NEW HAVEN, Conn., Sept. 02, 2025 ( GLOBE NEWSWIRE ) -- Specialty cancer diagnostics company Precipio, Inc. PRPO, has terminated its ATM ( At-The-Market ) instrument with investment bank Alliance Global Partners ( AGP ) .

Precipio Terminates Its ATM

GlobeNewswire • 1 week, 6 days ago • score: 0.24

Management Decision Further Reinforces Commitment to Responsible Capital Management Management Decision Further Reinforces Commitment to Responsible Capital Management ...

Precipio Announces Q2-2025 Shareholder Update Call

GlobeNewswire • 1 month, 2 weeks ago • score: 0.20

Conference Call to be held on August 14th, 2025 at 5:00 PM EST Conference Call to be held on August 14th, 2025 at 5:00 PM EST ...

Precipio Enters Into Agreement With Warrant Holder To Exercise Majority Of Warrants As Cashless - Precipio ( NASDAQ:PRPO )

Benzinga • 2 months ago • score: 0.19

NEW HAVEN, Conn., July 11, 2025 ( GLOBE NEWSWIRE ) -- Specialty cancer diagnostics company Precipio, Inc.

Precipio Enters Into Agreement With Warrant Holder To Exercise Majority Of Warrants As Cashless

GlobeNewswire • 2 months ago • score: 0.23

NEW HAVEN, Conn., July 11, 2025 ( GLOBE NEWSWIRE ) -- Specialty cancer diagnostics company Precipio, Inc. ( NASDAQ: PRPO ) has entered into an agreement with its largest warrant holder, amending the existing structure from cash exercise of warrants, to a revised structure whereby 100,000 ...

Precipio is requesting Shareholders/Brokers vote today to avoid costly adjournment and rescheduling of Annual Shareholders Meeting

GlobeNewswire • 2 months, 4 weeks ago • score: 0.19

NEW HAVEN, Conn., June 16, 2025 ( GLOBE NEWSWIRE ) -- Management of specialty cancer diagnostics company Precipio, Inc. ( NASDAQ: PRPO ) is requesting that shareholders instruct their brokers to vote their shares immediately today, no later than 11 pm Eastern Time.

Interval:

EMA1: EMA2:

AI Tools

Key Metrics

Trend: Downtrend

Source: Snapshot

Precipio, Inc., a cancer diagnostic and reagent technology company, provides diagnostic products and services in the United States oncology market. The company is headquartered in New Haven, Connecticut.

52W High

$17.78

52W Low

$3.90

MA Status:

50D: Below 200D: Below

Beta (~1 neutral, <0.9 lower risk)

1.09

Valuation

Fair

As of 2025-06-30 (Overview)

Trailing P/E (<15 better)

N/A

Forward P/E (<15 better)

15.43

EV/EBITDA (<8 favorable)

-1.15

EV/Revenue (<3 favorable)

1.42

P/S (TTM) (<3 favorable)

1.35

P/B (<3 favorable)

2.34

Ownership

Retail‑heavy

Source: Overview

Insiders (1–5% typical)

13.19%

Institutions (25–75% balanced)

5.75%

Shares Outstanding

1,619,600

Float

1,440,000

Dividend Yield (2–6% sweet spot)

N/A

Ex‑Dividend Date

N/A

Income & Growth

Profitability: Weak

As of 2025-06-30 (Overview)

Revenue (TTM)

21,242,000

Gross Profit (TTM)

9,492,000

EPS (TTM)

-1.19

Profit Margin (>10% good)

-0.08%

Operating Margin (TTM) (higher better)

-0.15%

ROE (TTM) (>15% strong)

-0.15%

EPS YoY (Quarterly) (>10% good)

N/A

Revenue YoY (Quarterly) (>8% good)

0.27

Momentum

Bearish momentum

Value

1.9858

Previous

2.0352

Trend

Falling

Signal Cross

No cross

As of

Sep. 12, 2025